Healthcare >> Analyst Interviews >> August 1, 2012
Higher-Efficiency Plays in Research and Diagnostics Despite Bearish Sentiments
Amit Bhalla is a Director at Citi Investment Research & Analysis. He joined the firm in June 2006 covering the life sciences tools and medical technology industries. Before joining the firm, Mr. Bhalla worked for Morgan Stanley as a Vice President for five years covering the medical technology and specialty pharmaceuticals sectors. Before that, he worked at Johnson & Johnson’s Ortho-McNeil unit, rotating through several departments including research and development, quality control and manufacturing. Mr. Bhalla holds a B.S. in biology from Cornell University and an MBA from Carnegie Mellon University’s Tepper School of Business. Profile
TWST: You cover life sciences tools, diagnostic tools and chromatography segments. Has the area you cover expanded since we spoke about a year ago?